RAMM Pharma Corp.
RAMM
CNSX
07/31/2024 | 04/30/2024 | 01/31/2024 | 10/31/2023 | 07/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 1.09M | 2.00M | 2.91M | 3.68M | 4.83M |
Total Receivables | 1.21M | 1.40M | 1.54M | 1.35M | 1.65M |
Inventory | 1.96M | 1.89M | 2.19M | 2.26M | 3.00M |
Prepaid Expenses | 94.40K | 91.60K | 84.20K | 155.60K | 25.10K |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 129.00K | 164.00K | 114.10K | 172.70K | 228.70K |
Total Current Assets | 4.48M | 5.54M | 6.84M | 7.62M | 9.73M |
|
|||||
Total Current Assets | 4.48M | 5.54M | 6.84M | 7.62M | 9.73M |
Net Property, Plant & Equipment | 13.56M | 13.56M | 13.91M | 13.71M | 15.42M |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | 192.80K | 245.30K | 310.00K | 354.50K | 433.40K |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 1.60M | 1.59M | 1.59M | 1.56M | 1.58M |
Total Assets | 19.84M | 20.94M | 22.65M | 23.26M | 27.15M |
|
|||||
Total Accounts Payable | 491.40K | 455.20K | 582.70K | 874.50K | 693.70K |
Total Accrued Expenses | 206.10K | 208.10K | 244.50K | 240.90K | 264.20K |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 109.80K | 142.90K | 164.80K | 162.30K | 166.10K |
Total Finance Division Other Current Liabilities | 482.40K | 883.10K | 821.70K | 634.50K | 701.40K |
Total Other Current Liabilities | 482.40K | 883.10K | 821.70K | 634.50K | 701.40K |
Total Current Liabilities | 1.29M | 1.69M | 1.81M | 1.91M | 1.83M |
|
|||||
Total Current Liabilities | 1.29M | 1.69M | 1.81M | 1.91M | 1.83M |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | 69.30K | 75.10K | 98.50K | 129.40K | 179.20K |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 1.36M | 1.76M | 1.91M | 2.04M | 2.00M |
|
|||||
Common Stock & APIC | 46.36M | 46.60M | 47.87M | 46.10M | 48.46M |
Retained Earnings | -39.43M | -38.91M | -38.67M | -35.60M | -34.66M |
Treasury Stock & Other | 11.55M | 11.48M | 11.54M | 10.71M | 11.35M |
Total Common Equity | 18.48M | 19.17M | 20.74M | 21.21M | 25.15M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 18.48M | 19.17M | 20.74M | 21.21M | 25.15M |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 18.48M | 19.17M | 20.74M | 21.21M | 25.15M |
|